SCIENCE: Clinical assessment of dysphagia in neurodegeneration (CADN): development, validity and reliability of a bedside tool for dysphagia assessment

The CADN is a reliable, valid, brief, quantifiable, and easily deployed assessment of swallowing in neurodegenerative disease. It is thus ideally suited for both clinical bedside assessment and future multicentre clinical trials in neurodegenerative disease.

 

Click here for more details.

Tags: , , ,

Related Post

Expanding the phenotype of Kleefstra syndrome: speech, language and cognition in 103 individuals

  • Posted on 31 March, 2024
    Speech and language impairments are core features of the neurodevelopmental genetic condition Kleefstra syndrome. The speech, language and cognitive profile...
    Read more

    Acoustic analysis of the effects of sustained wakefulness on speech

    • Posted on 25 January, 2024
      Exposing healthy adults to extended periods of wakefulness is known to induce changes in psychomotor functioning. The effect of fatigue...
      Read more

      Towards interpretable speech biomarkers: exploring MFCCs

      • Posted on 17 January, 2024
        While speech biomarkers of disease have attracted increased interest in recent years, a challenge is that features derived from signal...
        Read more